Editorial · 31 Jan 2025
Mini reviewPublished 30 Apr 2024
Redefining Drug Development: Artificial Intelligence's Part Redefining Drug Development: Artificial Intelligence
Department of Pharmacology, University of Otago, New Zealand
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Artificial intelligence (AI) has emerged as a transformative force in the field of drug discovery, revolutionizing traditional approaches and expediting the development of novel therapeutics. This abstract explores the pivotal role of AI in various stages of drug discovery, including target identification, compound design, virtual screening, predictive toxicology, clinical trial optimization, and drug repurposing. By harnessing the power of machine learning algorithms and big data analytics, AI enables researchers to navigate complex biological systems, identify promising drug targets, design optimized compounds, and accelerate clinical trials. Moreover, AI facilitates the repurposing of existing drugs for new indications, offering a cost-effective and time-efficient strategy for addressing unmet medical needs. The integration of AI into drug discovery processes holds immense promise for advancing healthcare, improving patient outcomes, and ushering in a new era of precision medicine.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacokinetics & Experimental Therapeutics.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacokinetics & Experimental Therapeutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “PartGerick Wilson”
